Page last updated: 2024-08-22

cladribine and Waldenstrom Macroglobulinemia

cladribine has been researched along with Waldenstrom Macroglobulinemia in 51 studies

Research

Studies (51)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	21 (41.18)	18.2507
2000's	19 (37.25)	29.6817
2010's	11 (21.57)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gaherova, L; Havrda, M; Kozak, T; Novak, J; Spicka, J	1
Heegaard, S; Jacoby, S; Philip, P; Prause, JU; Toft, PB	1
Ayrton, P; Berney, S; Hira-Kazal, R; Kothari, J; Maher, J; Sayar, Z	1
Treon, SP	1
Adamia, S; Ciccarelli, BT; Ghobrial, IM; Hatjiharissi, E; Hunter, ZR; Ioakimidis, L; Leleu, X; Manning, R; Moreau, AS; Patterson, CJ; Roccaro, A; Sacco, A; Soumerai, J; Treon, SP	1
Dimopoulos, MA; Eleutherakis-Papaiakovou, E; Gavriatopoulou, M; Kastritis, E; Migkou, M; Roussou, M; Tassidou, A; Terpos, E	1
Andreola, G; Bertolini, F; Billio, A; Calabrese, L; Fabbri, A; Frigeri, F; Laszlo, D; Martinelli, G; Rabascio, C; Radice, D; Rigacci, L; Saronni, L	1
Andreola, G; Bertolini, F; Billio, A; Calabrese, L; Fabbri, A; Frigeri, F; Laszlo, D; Mancuso, P; Martinelli, G; Pinto, A; Pruneri, G; Rabascio, C; Radice, D; Rigacci, L	1
Miller, HJ; Saven, A; Schram, ED; Sigal, DS	1
Anderson, KC; Ghobrial, IM; Rourke, M	1
Gertz, MA	2
Peinert, S; Seymour, JF	1
Andreola, G; Fabbri, A; Laszlo, D; Martinelli, G; Negri, M; Pinto, A; Rabascio, C; Rigacci, L	1
Baudo, F; deCataldo, F	1
Alinari, L; Baccarani, M; Stefoni, V; Tani, M; Zinzani, PL	1
Alexanian, R; Delasalle, K; Dimopoulos, MA; Gavino, M; Rankin, K; Weber, DM	1
Bloch, KJ; Carey, RW; Krishna, VM	1
Caracciolo, F; Cecconi, N; Cervetti, G; Galimberti, S; Petrini, M	1
Aslan, DL; Eastlund, T; Long-Tsai, M; Peterson, BA	1
Gibson, J; Ho, PJ; Iland, H; Joshua, DE; Ling, S; Watson, G; Young, G	1
Birchall, J; Johnson, SA; Luckie, C; Oscier, DG; Owen, RG	1
Agazzi, A; Andreola, G; Bassi, S; Bertazzoni, P; Gigli, F; Laszlo, D; Martinelli, G	1
Gladstone, DE	1
Ciesielski, D; Grieb, P; Hellmann, A; Zaucha, JM	1
Alexanian, R; Dimopoulos, MA; Kantarjian, H; Keating, M; Weber, DM	1
Richards, AI	1
Alexanian, R; Delasalle, KB; Dimopoulos, MA; Keating, M; Weber, D	1
Alexanian, R; Dimopoulos, MA; Estey, EE; Kantarjian, H; Keating, MJ; O'Brien, S	1
Bosly, A; Delannoy, A; Ferrant, A; Martiat, P; Michaux, JL; Zenebergh, A	1
Bosly, A; Brousset, P; Delannoy, A; Pris, J; Riga-Huguet, F; Schlaifer, D	1
Alexanian, R; Cabanillas, F; Delasalle, K; Dimopoulos, MA; Estey, E; Kantarjian, H; Keating, M; O'Brien, S; Rose, E; Weber, D	1
Alexanian, R; Delasalle, K; Dimopoulos, MA; Estey, E; Freireich, EJ; Kantarjian, H; Keating, MJ; O'Brien, S	1
Bosly, A; Delannoy, A; Ferrant, A; Filleul, B; Martiat, P; Michaux, JL; Mineur, P; Montfort, L; Straetmans, N; Van Den Neste, E; Vandercam, B	1
Piro, LD	1
Hoffman, MA	1
Kantarjian, H; Keating, MJ; O'Brien, S	1
Baldinger, C; Bettelheim, P; Chott, A; Fridrik, MA; Jäger, G; Krieger, O	1
Piro, LD; Saven, A	1
Betticher, DC; Cerny, T; Egger, T; Fey, MF; Hess, U; Hsu Schmitz, SF; Pugin, P; Ratschiller, D; Stalder, M; von Rohr, A	1
Burian, C; Liu, ES; Miller, WE; Saven, A	1
Alberto, P; Betticher, DC; Guetty-Alberto, M; Iten, PA; Laurencet, FM; Zulian, GB	1
Bosly, A; Delannoy, A; Ferrant, A; Michaux, JL; Van Den Neste, E	1
Louie, D; Michaeli, J; Niesvizky, R; Zhu, AX	1
Bieniaszewska, M; Hałaburda, K; Hellmann, A; Lewandowski, K; Robak, T; Zaucha, JM	1
Saven, A; Tetreault, SA	1
Wong, SS; Woo, PC; Yuen, KY	1
Owen, RG	1
Alvarez-Ferreira, J; Canales, MA; Delgado, J; Garcia, B; Garcia-Grande, A; Hernandez-Navarro, F	1
Halaburda, K; Hellmann, A; Lewandowski, K	1
Barlogie, B; Desikan, KR; Dhodapkar, MV	1

Reviews

12 review(s) available for cladribine and Waldenstrom Macroglobulinemia

Article	Year
Rituximab-based treatments in Waldenström's macroglobulinemia. Clinical lymphoma & myeloma, 2009, Volume: 9, Issue:1 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Doxorubicin; Humans; Rituximab; Vidarabine; Waldenstrom Macroglobulinemia	2009
Beyond hairy cell: the activity of cladribine in other hematologic malignancies. Blood, 2010, Oct-21, Volume: 116, Issue:16 Topics: Antineoplastic Agents; Cladribine; Hematologic Neoplasms; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Waldenstrom Macroglobulinemia	2010
Review of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patients. Leukemia & lymphoma, 2010, Volume: 51, Issue:10 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Chlorambucil; Cladribine; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Rituximab; Treatment Outcome; Vidarabine; Waldenstrom Macroglobulinemia	2010
Waldenström's macroglobulinemia: a review of therapy. Leukemia & lymphoma, 2002, Volume: 43, Issue:8 Topics: Adrenal Cortex Hormones; Alkylating Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cladribine; Hematopoietic Stem Cell Transplantation; Humans; Plasma Exchange; Rituximab; Splenectomy; Transplantation, Autologous; Vidarabine; Waldenstrom Macroglobulinemia	2002
Guidelines on the management of Waldenström macroglobulinaemia. British journal of haematology, 2006, Volume: 132, Issue:6 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cladribine; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Immunologic Factors; Immunosuppressive Agents; Plasma Exchange; Prognosis; Rituximab; Stem Cell Transplantation; Thalidomide; Vidarabine; Waldenstrom Macroglobulinemia	2006
Cladribine in the treatment of low-grade non-Hodgkin's lymphoma. Seminars in hematology, 1996, Volume: 33, Issue:1 Suppl 1 Topics: Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Skin Neoplasms; Waldenstrom Macroglobulinemia	1996
Cladribine for the treatment of indolent non-Hodgkin's lymphomas. Seminars in hematology, 1996, Volume: 33, Issue:1 Suppl 1 Topics: Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Humans; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Waldenstrom Macroglobulinemia	1996
Purine analogs in chronic lymphocytic leukemia and Waldenström's macroglobulinemia. Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7 Suppl 6 Topics: Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Purine Nucleosides; Vidarabine; Waldenstrom Macroglobulinemia	1996
2-Chlorodeoxyadenosine treatment of lymphoma. Cancer treatment and research, 1996, Volume: 85 Topics: Adenosine Deaminase; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cladribine; Humans; Lymphoma; Lymphoma, B-Cell; Lymphoma, T-Cell, Cutaneous; Pentostatin; Vidarabine; Waldenstrom Macroglobulinemia	1996
Treatment options in Waldenström's macroglobulinaemia: the role of the purine analogues. Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:6 Topics: Alkylating Agents; Antimetabolites; Chlorambucil; Cladribine; Clinical Trials as Topic; Drug Resistance; Drug Therapy, Combination; Guidelines as Topic; Humans; Middle Aged; Pentostatin; Plasmapheresis; Purine Nucleosides; Quality of Life; Vidarabine; Waldenstrom Macroglobulinemia	2001
Radiation therapy and combination of cladribine, cyclophosphamide, and prednisone as treatment of Bing-Neel syndrome: Case report and review of the literature. American journal of hematology, 2002, Volume: 69, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Brain; Cladribine; Combined Modality Therapy; Cyclophosphamide; Dizziness; Glucocorticoids; Humans; Immunoglobulin M; Magnetic Resonance Imaging; Male; Muscle Weakness; Prednisone; Stereotaxic Techniques; Waldenstrom Macroglobulinemia	2002
Waldenström's macroglobulinemia. Current treatment options in oncology, 2000, Volume: 1, Issue:2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; beta 2-Microglobulin; Chlorambucil; Cladribine; Clinical Trials as Topic; Combined Modality Therapy; Humans; Interferon-alpha; Neoplasm Recurrence, Local; Plasmapheresis; Rituximab; Survival Rate; Vidarabine; Waldenstrom Macroglobulinemia	2000

Trials

13 trial(s) available for cladribine and Waldenstrom Macroglobulinemia

Article	Year
Expression of the human concentrative nucleotide transporter 1 (hCNT1) gene correlates with clinical response in patients affected by Waldenström's Macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) undergoing a combination treatment with 2-chlor Leukemia research, 2010, Volume: 34, Issue:4 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cladribine; Female; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Membrane Transport Proteins; Middle Aged; Models, Biological; Prognosis; Rituximab; Treatment Outcome; Waldenstrom Macroglobulinemia	2010
Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase II multicenter study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, May-01, Volume: 28, Issue:13 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Disease-Free Survival; Drug Administration Schedule; Female; Genotype; Humans; Immunophenotyping; Injections, Subcutaneous; Italy; Kaplan-Meier Estimate; Male; Membrane Transport Proteins; Middle Aged; Patient Selection; Phenotype; Prospective Studies; Rituximab; Time Factors; Treatment Outcome; Waldenstrom Macroglobulinemia; ZAP-70 Protein-Tyrosine Kinase	2010
Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine as therapy in untreated and relapsed Waldenström's macroglobulinemia. Clinical lymphoma, myeloma & leukemia, 2011, Volume: 11, Issue:1 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Drug Administration Schedule; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Prospective Studies; Recurrence; Rituximab; Treatment Outcome; Waldenstrom Macroglobulinemia	2011
Role of low-dose 2-CdA in refractory or resistant lymphoplasmocytic lymphoma. Journal of chemotherapy (Florence, Italy), 2004, Volume: 16, Issue:4 Topics: Aged; Antineoplastic Agents; Cladribine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Probability; Prognosis; Prospective Studies; Risk Assessment; Severity of Illness Index; Survival Analysis; Treatment Outcome; Waldenstrom Macroglobulinemia	2004
Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: identification of prognostic factors. Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:1 Topics: Adult; Aged; Cladribine; Humans; Middle Aged; Neutropenia; Prognosis; Recurrence; Remission Induction; Survival Rate; Waldenstrom Macroglobulinemia	1995
Treatment of Waldenstrom's macroglobulinemia with nucleoside analogues. Leukemia & lymphoma, 1993, Volume: 11 Suppl 2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Humans; Middle Aged; Remission Induction; Survival Rate; Vidarabine; Waldenstrom Macroglobulinemia	1993
2-Chlorodeoxyadenosine therapy in Waldenstrom's macroglobulinaemia. Nouvelle revue francaise d'hematologie, 1994, Volume: 36, Issue:4 Topics: Aged; Aged, 80 and over; Cladribine; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neutropenia; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia; Treatment Outcome; Waldenstrom Macroglobulinemia	1994
Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:12 Topics: Adult; Aged; Aged, 80 and over; CD4 Lymphocyte Count; Cladribine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Recurrence; Remission Induction; Survival Analysis; Treatment Outcome; Waldenstrom Macroglobulinemia	1994
Treatment of Waldenstrom macroglobulinemia with 2-chlorodeoxyadenosine. Annals of internal medicine, 1993, Feb-01, Volume: 118, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Cladribine; Female; Follow-Up Studies; Humans; Immunoglobulin M; Male; Middle Aged; Remission Induction; Waldenstrom Macroglobulinemia	1993
First-line treatment of Waldenström's disease with cladribine. Arbeitsgemeinschaft Medikamentöse Tumortherapie. Annals of hematology, 1997, Volume: 74, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Humans; Interferon Type I; Male; Middle Aged; Neutropenia; Prospective Studies; Recombinant Proteins; Remission Induction; Waldenstrom Macroglobulinemia	1997
Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemia. Swiss Group for Clinical Cancer Research (SAKK). British journal of haematology, 1997, Volume: 99, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Cladribine; Female; Humans; Immunosuppressive Agents; Injections, Intradermal; Male; Middle Aged; Neutropenia; Opportunistic Infections; Thrombocytopenia; Treatment Outcome; Waldenstrom Macroglobulinemia	1997
Bolus administration of cladribine in the treatment of Waldenström macroglobulinaemia. British journal of haematology, 1998, Volume: 103, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Humans; Infusions, Intravenous; Middle Aged; Recurrence; Survival Analysis; Waldenstrom Macroglobulinemia	1998
Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenström's macroglobulinemia. European journal of haematology, 1999, Volume: 63, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Retrospective Studies; Waldenstrom Macroglobulinemia	1999

Other Studies

26 other study(ies) available for cladribine and Waldenstrom Macroglobulinemia

Article	Year
Clinical case: idelalisib-induced immunoglobulin flare. Immunopharmacology and immunotoxicology, 2017, Volume: 39, Issue:4 Topics: Aged; Cladribine; Female; Humans; Immunoglobulin M; Leukemia, Lymphocytic, Chronic, B-Cell; Purines; Quinazolinones; Rituximab; Waldenstrom Macroglobulinemia	2017
Nodular amyloidosis of all four eyelids: first presenting symptom of Waldenström macroglobulinaemia. Acta ophthalmologica, 2014, Volume: 92, Issue:4 Topics: Aged; Amyloidosis; Antibodies, Monoclonal, Murine-Derived; Cladribine; Drug Therapy, Combination; Eyelid Diseases; Humans; Immunosuppressive Agents; Male; Rituximab; Tomography, X-Ray Computed; Waldenstrom Macroglobulinemia	2014
Cryoglobulinaemia identified by repeated analytical failure of laboratory tests. Lancet (London, England), 2014, Jan-25, Volume: 383, Issue:9914 Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood Specimen Collection; Cladribine; Combined Modality Therapy; Cryoglobulinemia; Humans; Male; Plasmapheresis; Rituximab; Waldenstrom Macroglobulinemia	2014
How I treat Waldenström macroglobulinemia. Blood, 2015, Aug-06, Volume: 126, Issue:6 Topics: Adenine; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bendamustine Hydrochloride; Boronic Acids; Bortezomib; Cladribine; Cyclophosphamide; Everolimus; Gene Expression; Genetic Predisposition to Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin M; Male; Middle Aged; Molecular Targeted Therapy; Myeloid Differentiation Factor 88; Nitrogen Mustard Compounds; Oligopeptides; Piperidines; Plasmapheresis; Pyrazines; Pyrazoles; Pyrimidines; Receptors, CXCR4; Rituximab; Sirolimus; Transplantation, Autologous; Vidarabine; Waldenstrom Macroglobulinemia	2015
Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Jan-10, Volume: 27, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Cell Transformation, Neoplastic; Chlorambucil; Cladribine; Female; Follow-Up Studies; Humans; Incidence; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Nucleosides; Retrospective Studies; Vidarabine; Waldenstrom Macroglobulinemia	2009
What's new in Waldenström macroglobulinemia. Leukemia & lymphoma, 2010, Volume: 51, Issue:10 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Chlorambucil; Cladribine; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Rituximab; Treatment Outcome; Vidarabine; Waldenstrom Macroglobulinemia	2010
Unresolved issues in the comparison of therapies and determination of responses in Waldenström macroglobulinemia. Leukemia & lymphoma, 2010, Volume: 51, Issue:10 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Chlorambucil; Cladribine; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Rituximab; Treatment Outcome; Vidarabine; Waldenstrom Macroglobulinemia	2010
Successful treatment with 2-chlorodeoxyadenosine of secondary lesions of the central nervous system in low-grade lymphoid malignancies. American journal of hematology, 2002, Volume: 70, Issue:4 Topics: Central Nervous System Neoplasms; Cladribine; Disease-Free Survival; Female; Humans; Leukemia, Hairy Cell; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Middle Aged; Neoplasms, Second Primary; Treatment Outcome; Waldenstrom Macroglobulinemia	2002
Waldenstrom's macroglobulinemia: is there a place and time for a cease-fire? Leukemia research, 2003, Volume: 27, Issue:5 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case Management; Chlorambucil; Cladribine; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Immunoglobulin M; Male; Middle Aged; Mitoxantrone; Plasmapheresis; Prednisone; Rituximab; Severity of Illness Index; Thalidomide; Vidarabine; Vinblastine; Vincristine; Vinorelbine; Waldenstrom Macroglobulinemia	2003
2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia. Seminars in oncology, 2003, Volume: 30, Issue:2 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Glucocorticoids; Humans; Middle Aged; Prednisone; Prognosis; Remission Induction; Rituximab; Survival Analysis; Waldenstrom Macroglobulinemia	2003
Marked increase in serum IgM during treatment of Waldenstrom's macroglobulinemia with cladribine. The New England journal of medicine, 2003, May-15, Volume: 348, Issue:20 Topics: Aged; Antineoplastic Agents; Cladribine; Female; Humans; Immunoglobulin M; Male; Middle Aged; Waldenstrom Macroglobulinemia	2003
Early-onset autoimmune hemolytic anemia after cladribine therapy for Waldenström's macroglobulinemia. Transfusion, 2006, Volume: 46, Issue:1 Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Autoantibodies; Cladribine; Erythrocytes; Hemolysis; Humans; Immunoglobulin G; Male; Middle Aged; Waldenstrom Macroglobulinemia	2006
Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases: natural evolution or iatrogenic causation? American journal of hematology, 2006, Volume: 81, Issue:2 Topics: Aged; Antineoplastic Agents, Alkylating; Cell Transformation, Neoplastic; Cladribine; Disease Progression; Fatal Outcome; Female; Humans; Immunosuppression Therapy; Lymphoma, Large B-Cell, Diffuse; Male; Purine Nucleosides; Waldenstrom Macroglobulinemia	2006
Severe neuropathy in a patient with Waldenstrom disease: from a challenging diagnosis to clinical improvement by innovative therapy. Leukemia & lymphoma, 2006, Volume: 47, Issue:9 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Rituximab; Waldenstrom Macroglobulinemia	2006
Refractory Waldenström's macroglobulinaemia responsive to 2-chlorodeoxyadenosine and mycophenolate mofetil. Leukemia research, 2008, Volume: 32, Issue:9 Topics: Cladribine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Middle Aged; Mycophenolic Acid; Neoplasm Recurrence, Local; Treatment Outcome; Waldenstrom Macroglobulinemia	2008
2-Chloro-2'-deoxyadenosine (2-CdA) treatment in a patient with Waldenström's macroglobulinaemia complicated by severe neutrocytopenia. Archivum immunologiae et therapiae experimentalis, 1994, Volume: 42, Issue:1 Topics: Aged; Animals; Cladribine; Humans; Immunosuppressive Agents; Male; Mice; Neutropenia; Waldenstrom Macroglobulinemia	1994
2Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:3 Topics: Aged; Antimetabolites, Antineoplastic; Cladribine; Drug Resistance; Female; Humans; Male; Middle Aged; Recurrence; Treatment Outcome; Vidarabine Phosphate; Waldenstrom Macroglobulinemia	1994
Response of meningeal Waldenström's macroglobulinemia to 2-chlorodeoxyadenosine. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:9 Topics: Cladribine; Humans; Male; Meningeal Neoplasms; Middle Aged; Remission Induction; Waldenstrom Macroglobulinemia	1995
Secondary neoplasms in two patients treated with purine analogues. Nouvelle revue francaise d'hematologie, 1994, Volume: 36, Issue:4 Topics: Acute Disease; Aged; Cladribine; Female; Humans; Immunocompromised Host; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Melanoma; Neoplasms, Second Primary; Skin Neoplasms; Vidarabine; Waldenstrom Macroglobulinemia	1994
Infectious complications after 2-chlorodeoxyadenosine therapy. European journal of haematology, 1996, Volume: 56, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cladribine; Cohort Studies; Disease Susceptibility; Female; Fever; Hematologic Diseases; Herpesviridae Infections; Humans; Immunologic Deficiency Syndromes; Incidence; Infections; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Risk Factors; Waldenstrom Macroglobulinemia	1996
Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies. British journal of cancer, 1999, Volume: 79, Issue:7-8 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Drug Administration Schedule; Feasibility Studies; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Waldenstrom Macroglobulinemia	1999
Cladribine for Waldenström's macroglobulinaemia. British journal of haematology, 1999, Volume: 104, Issue:4 Topics: Cladribine; Disease Progression; Humans; Immunosuppressive Agents; Survival Analysis; Treatment Outcome; Waldenstrom Macroglobulinemia	1999
Epstein-Barr virus-associated lymphoma after treatment of macroglobulinemia with cladribine. The New England journal of medicine, 1999, Jul-01, Volume: 341, Issue:1 Topics: Aged; Cladribine; Fatal Outcome; Female; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Waldenstrom Macroglobulinemia	1999
Delayed onset of autoimmune hemolytic anemia complicating cladribine therapy for Waldenström macroglobulinemia. Leukemia & lymphoma, 2000, Volume: 37, Issue:1-2 Topics: Aged; Anemia, Hemolytic, Autoimmune; Cladribine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Waldenstrom Macroglobulinemia	2000
Candida tropicalis and Penicillium marneffei mixed fungaemia in a patient with Waldenström's macroglobulinaemia. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2001, Volume: 20, Issue:2 Topics: Aged; Candida; Candidiasis; Cladribine; Fatal Outcome; Fungemia; Humans; Immunosuppressive Agents; Male; Penicillium; Waldenstrom Macroglobulinemia	2001
Fludarabine therapy in Waldenström's macroglobulinemia patients treated previously with 2-chlorodeoxyadenosine. Leukemia & lymphoma, 2002, Volume: 43, Issue:2 Topics: Aged; Cladribine; Drug Evaluation; Humans; Immunoglobulin M; Immunosuppressive Agents; Middle Aged; Remission Induction; Treatment Outcome; Vidarabine; Waldenstrom Macroglobulinemia	2002